
               
               
               Clinical Pharmacology:
               Carbetapentane citrate is a centrally acting non-narcotic antitussive.

                  
Guaifenesin is an expectorant. Its action increases the output of respiratory tract fluid by reducing 
adhesiveness and surface tension. Sinus and bronchial drainage is improved and dry, nonproductive 
coughs become more productive and less frequent.

               
               
            
         